Skip to main content
Equibles

PRINCIPAL FINANCIAL GROUP INC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1126328 DES MOINES, IA
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$35,455,033
+$13,346,260 QoQ
Shares Held
645,341
-3.0% QoQ
Ownership
0.422%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 426 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. TGTX ranks #16 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 873,502 $232,980,453
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 389,511 $193,481,798
3 CYTK
Cytokinetics Inc
 1,311,664 $111,740,655
4 GPCR
Structure Therapeutics Inc.
 1,752,753 $94,070,253
5 INSM
INSMED Inc
 856,126 $91,280,154
6 AXSM
Axsome Therapeutics, Inc.
 332,642 $81,420,782
7 BBIO
BridgeBio Pharma, Inc.
 1,024,423 $76,299,024
8 REGN
Regeneron Pharmaceuticals, Inc.
 121,053 $75,481,386

All Filings in TGTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,455,033 645,341
2026-03-31 $22,108,773 665,526
2025-12-31 $25,272,529 847,787
2025-09-30 $28,328,212 784,172
2025-06-30 $28,672,296 796,674
2025-03-31 $33,161,063 841,011
2024-12-31 $24,988,537 830,184
2024-09-30 $18,061,477 772,188
2024-06-30 $832,874 46,817
2024-03-31 $538,038 35,374
2023-12-31 $581,607 34,052
2023-09-30 $281,229 33,640
2023-06-30 $1,293,641 52,079
2023-03-31 $962,198 63,976
2022-12-31 $468,822 39,630
2022-09-30 $212,574 35,908
2022-06-30 $155,945 36,693
2022-03-31 $379,419 39,897
2021-12-31 $743,299 39,121
2021-09-30 $1,839,850 55,284
2021-06-30 $2,072,316 53,424
2021-03-31 $2,532,764 52,547
2020-12-31 $2,712,946 52,152
2020-09-30 $971,976 36,322
2020-06-30 $721,363 37,031
2020-03-31 $247,879 25,191